SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001437749-21-009715
Filing Date
2021-04-23
Accepted
2021-04-23 16:04:26
Documents
2
Period of Report
2021-04-21

Document Format Files

Seq Description Document Type Size
1 FORM 3 rdgdoc.html 3  
1 FORM 3 rdgdoc.xml 3 1346
2 wheadonpoa.htm EX-24 8794
  Complete submission text file 0001437749-21-009715.txt   11869
Mailing Address 385 OYSTER POINT BOULEVARD, SUITE 9A SOUTH SAN FRANCISCO CA 94080
Business Address 385 OYSTER POINT BOULEVARD, SUITE 9A SOUTH SAN FRANCISCO CA 94080 (650) 550-3500
Vaxart, Inc. (Issuer) CIK: 0000072444 (see all company filings)

IRS No.: 591212264 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O ASSERTIO THERAPEUTICS, INC. 100 SOUTH SAUNDERS ROAD, SUITE 300 LAKE FOREST IL 60045
Business Address
Wheadon David E. (Reporting) CIK: 0001789507 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35285 | Film No.: 21849709